MPS-IIIA or Autism Spectrum Disorder?: Discrimination and Treatment

Kimberly A. Schreck; Lindsay M. Knapp

doi:10.1007/s40489-021-00298-z

MPS-IIIA or Autism Spectrum Disorder? Discrimination and Treatment

Kimberly A. Schreck
, Lindsay M. Knapp

School of Behavioral Sciences & Education (Harrisburg)

Research output: Contribution to journal › Review article › peer-review

3 Scopus citations

Abstract

Children with mucopolysaccharidosis IIIA (MPS-IIIA) may receive a diagnosis of autism spectrum disorder (ASD) due to MPS-IIIA’s initial symptom similarities with ASD. This may lead to professionals receiving referrals to work with these children but unaware of how these children may respond differently to treatment. To appropriately work with these children, clinicians must obtain knowledge of the symptoms, progressions, regression, comorbidities, and clinical interventions. This manuscript guides clinicians on the discrimination of MPS-IIIA from ASD for (a) physiological symptoms, (b) skill development and regression of skills, and (c) behavior problems from infancy to adolescence. The manuscript also provides available intervention research.

Original language	English (US)
Journal	Review Journal of Autism and Developmental Disorders
DOIs	https://doi.org/10.1007/s40489-021-00298-z
State	Accepted/In press - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Developmental Neuroscience
Cognitive Neuroscience
Psychiatry and Mental health
Behavioral Neuroscience

Access to Document

10.1007/s40489-021-00298-z

Cite this

@article{89622d3407154be09babbae2f55e4ba2,

title = "MPS-IIIA or Autism Spectrum Disorder?: Discrimination and Treatment",

abstract = "Children with mucopolysaccharidosis IIIA (MPS-IIIA) may receive a diagnosis of autism spectrum disorder (ASD) due to MPS-IIIA{\textquoteright}s initial symptom similarities with ASD. This may lead to professionals receiving referrals to work with these children but unaware of how these children may respond differently to treatment. To appropriately work with these children, clinicians must obtain knowledge of the symptoms, progressions, regression, comorbidities, and clinical interventions. This manuscript guides clinicians on the discrimination of MPS-IIIA from ASD for (a) physiological symptoms, (b) skill development and regression of skills, and (c) behavior problems from infancy to adolescence. The manuscript also provides available intervention research.",

author = "Schreck, \{Kimberly A.\} and Knapp, \{Lindsay M.\}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2022",

doi = "10.1007/s40489-021-00298-z",

language = "English (US)",

journal = "Review Journal of Autism and Developmental Disorders",

issn = "2195-7177",

publisher = "Springer New York",

}

TY - JOUR

T1 - MPS-IIIA or Autism Spectrum Disorder?

T2 - Discrimination and Treatment

AU - Schreck, Kimberly A.

AU - Knapp, Lindsay M.

PY - 2022

Y1 - 2022

N2 - Children with mucopolysaccharidosis IIIA (MPS-IIIA) may receive a diagnosis of autism spectrum disorder (ASD) due to MPS-IIIA’s initial symptom similarities with ASD. This may lead to professionals receiving referrals to work with these children but unaware of how these children may respond differently to treatment. To appropriately work with these children, clinicians must obtain knowledge of the symptoms, progressions, regression, comorbidities, and clinical interventions. This manuscript guides clinicians on the discrimination of MPS-IIIA from ASD for (a) physiological symptoms, (b) skill development and regression of skills, and (c) behavior problems from infancy to adolescence. The manuscript also provides available intervention research.

AB - Children with mucopolysaccharidosis IIIA (MPS-IIIA) may receive a diagnosis of autism spectrum disorder (ASD) due to MPS-IIIA’s initial symptom similarities with ASD. This may lead to professionals receiving referrals to work with these children but unaware of how these children may respond differently to treatment. To appropriately work with these children, clinicians must obtain knowledge of the symptoms, progressions, regression, comorbidities, and clinical interventions. This manuscript guides clinicians on the discrimination of MPS-IIIA from ASD for (a) physiological symptoms, (b) skill development and regression of skills, and (c) behavior problems from infancy to adolescence. The manuscript also provides available intervention research.

UR - https://www.scopus.com/pages/publications/85123496619

UR - https://www.scopus.com/pages/publications/85123496619#tab=citedBy

U2 - 10.1007/s40489-021-00298-z

DO - 10.1007/s40489-021-00298-z

M3 - Review article

AN - SCOPUS:85123496619

SN - 2195-7177

JO - Review Journal of Autism and Developmental Disorders

JF - Review Journal of Autism and Developmental Disorders

ER -